Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Common Equity (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Common Equity for 15 consecutive years, with $407000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity rose 100.74% year-over-year to $407000.0, compared with a TTM value of $407000.0 through Sep 2025, up 100.74%, and an annual FY2025 reading of $407000.0, changed N/A over the prior year.
  • Common Equity was $407000.0 for Q3 2025 at SRx Health Solutions, up from -$45.9 million in the prior quarter.
  • Across five years, Common Equity topped out at $62.7 million in Q3 2021 and bottomed at -$63.7 million in Q4 2024.
  • Average Common Equity over 5 years is $8.0 million, with a median of $14.3 million recorded in 2021.
  • The sharpest move saw Common Equity crashed 2260.57% in 2024, then surged 628.64% in 2025.
  • Year by year, Common Equity stood at $57.9 million in 2021, then plummeted by 62.8% to $21.5 million in 2022, then tumbled by 86.31% to $2.9 million in 2023, then plummeted by 2260.57% to -$63.7 million in 2024, then skyrocketed by 100.64% to $407000.0 in 2025.
  • Business Quant data shows Common Equity for SRXH at $407000.0 in Q3 2025, -$45.9 million in Q2 2025, and $8.0 million in Q1 2025.